Basic | |
---|---|
Market Cap | $521.35M |
Price | $0.94 |
52 Week Range | 0.3551-2.06 |
Beta | 1.76 |
Margins | |
Gross Profit Margin | 34.95% |
Operating Profit Margin | -76.20% |
Net Profit Margin | -79.19% |
Valuation (TTM) | |
P/E Ratio | -0.96 |
Price to Sales Ratio | 1.02 |
Price to Book Ratio | 2.54 |
PEG Ratio | -0.97 |
Drug Manufacturers - Specialty & Generic
Healthcare
2,505
2019-05-06T00:00:00.000Z
Columbia Care Inc. cultivates, manufactures, and provides cannabis products and related services. It offers flowers, edibles, oils, and tablets under the Seed & Strain, Triple Seven, gLeaf, Classix, Press, Amber, and Platinum Label CBD brands. The company holds licenses in 18 jurisdictions in the United States and the European Union. As of June 15, 2022, it operated 131 facilities, including 99 dispensaries and 32 cultivation and manufacturing facilities. The company was founded in 2012 and is headquartered in New York, New York.
212-634-7100
680 Fifth Avenue, New York, NY, 10019, US
0001776738